• 1
    Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973–1998. Bethesda: National Cancer Institute, 2001.
  • 2
    Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study [see comments]. JAMA. 1994; 272: 947954.
  • 3
    Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000; 88: 114123.
  • 4
    Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998; 82: 13101318.
  • 5
    Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 14871491.
  • 6
    SmedleyBD, StithA, NelsonAR, editors. Unequal treatment—confronting racial and ethnic disparities in health care. Washington, DC: Institute of Medicine, National Academy Press, 2002.
  • 7
    Roach M III, Cirrincione C, Budman D, et al. Race and survival from breast cancer: based on Cancer and Leukemia Group B Trial 8541. Cancer J Sci Am. 1997; 3: 107112.
  • 8
    Dignam JJ, Redmond CK, Fisher B, Costantino JP, Edwards BK. Prognosis among African-American women and white women with lymph node negative breast cancer. Cancer. 1997; 80: 8090.
  • 9
    Dignam JJ. Efficacy of system adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr. 2001; 30: 3643.
  • 10
    Diehr P, Yergan J, Chu J, et al. Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care. 1989; 27: 942958.
  • 11
    Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341: 11981205.
  • 12
    Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer. 1996; 77: 308314.
  • 13
    Simon MS, Severson RK. Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol. 1997; 176: S233S239.
  • 14
    Greenwald HP, Polissar NL, Dayal HH. Race, socioeconomic status and survival in three female cancers. Ethn Health 1996; 1: 6575.
  • 15
    Edwards MJ, Gamel JW, Vaughn WP, Wrightson WR. Infiltrating ductal carcinoma of the breast: the survival impact of race. J Clin Oncol. 1998; 16: 26932699.
  • 16
    Lyman GH, Kuderer NM, Lyman SL, Cox CE, Reintgen D, Baekey P. Importance of race on breast cancer survival. Ann Surg Oncol. 1997; 4: 8087.
  • 17
    Ragland KE, Selvin S, Merrill DW. Black/white differences in stage-specific survival: analysis of seven selected sites. Am J Epidemiol. 1991; 133: 672682.
  • 18
    Coates RJ, Clark WS, Eley JW, Greenburg RS, Huguley CM, Brown RL. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst. 1990; 82: 16841692.
  • 19
    Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL. Effects of race and socioeconomic status on survival of 1332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997; 4: 111118.
  • 20
    Heimann R, Ferguson D, Powers C, Suri D, Weichselbaum RR, Hellman S. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997; 15: 2337.
  • 21
    Perkins P, Cookley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer. 1996; 78: 12411247.
  • 22
    Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947954.
  • 23
    Surveillance, Epidemiology, and End Results Program. SEER*Stat version 4.2. SEER cancer incidence public-use database, 1973–1999. Bethesda: National Cancer Institute, 2002.
  • 24
    Shambaugh EM, Ries LAG, Kruse MA, Platz CE, Ryan RF, Weiss MA. SEER extent of disease—1988 codes and coding instructions, 2nd edition. Bethesda: National Cancer Institute, 1992.
  • 25
    National Cancer Institute. Breast cancer (PDQ) treatment-health professionals. Bethesda: National Cancer Institute, 2001. Available from URL: [14 Jan 2003].
  • 26
    Seiffert JE. SEER Program: comparative staging guide for cancer. Bethesda: National Cancer Institute, 1993.
  • 27
    Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates [see comments]. J Natl Cancer Inst. 1996; 88: 15711579.
  • 28
    National Institutes of Health Consensus Development Panel. Consensus Development Conference on the management of clinically localized prostate cancer. J Natl Cancer Inst Monogr. 1999; 7: 1174.
  • 29
    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research—principles and quantitative methods. Belmont: Lifetime Learning Publications, 1982.
  • 30
    Chu KC, Anderson WF. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res. 2002; 74: 199211.
  • 31
    Brinton LA, Benichou J, Gammon MD, Brogan DR, Coates R, Schoenberg JB. Ethnicity and variation in breast cancer incidence. Int J Cancer. 1997; 73: 349355.
  • 32
    Freeman HP. Voices of a broken system: real people, real problems. President's cancer panel—report of the chairman, 2000–2001. Bethesda: US Department of Health and Human Services, 2001.
  • 33
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334357.
  • 34
    Hunter CP, Redmond CK, Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993; 85: 11291137.
  • 35
    Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992 and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 17041713.
  • 36
    Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage disease of breast and cervical cancer: the impact of age, race, social class and hospital type. Am J Public Health. 1991; 81: 646649.
  • 37
    Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996; 78: 13951402.
  • 38
    McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996; 12: 282288.
  • 39
    Swanson GM, Ragheb NE, Lin CS, et al. Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease [see comments]. Cancer. 1993; 72: 788798.
  • 40
    Chu KC, Tarone RE, Brown CC. Breast cancer trends of black women compared with white women. Arch Fam Med. 1999; 8: 521528.
  • 41
    McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis and survival among older women. J Am Geriatr Soc. 2000; 48: 12261233.